The absence of other thrombophilias (normal antiphospholipid antibodies, protein C/S, factor V Leiden, and JAK2 mutations) further isolates MTHFR-related hyperhomocysteinemia as the primary contributor. The gene discussed is JAK2; the disease is hyperhomocysteinemia.